Estrogen receptor antagonist fulvestrant inhibits proliferation and promotes apoptosis of prolactinoma cells by regulating the IRE1/XBP1 signaling pathway - Wang, C; Bai, M; Wang, X (Mol Med Rep, 2018)
et al.